SCHEMBL1193589

SCHEMBL1193589

C=CCC1(C(=O)O)C2CC3CC(C2)CC1C3

nearest known ligand 0.37

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 10/20 0.37
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
ALDH1A1 P00352 1/20 0.33
TSHR P16473 1/20 0.31
DPP4 P27487 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4400847 0.84 HSD11B1 (0.34) HSD11B1MEN1KMT2AALDH1A1
SCHEMBL5712564 0.74 HSD11B1 (0.40) HSD11B1MEN1KMT2A
SCHEMBL6553000 0.71
SCHEMBL719792 0.71 ALDH1A1 (0.39) ALDH1A1
SCHEMBL5514094 0.69 ALDH1A1 (0.38) ALDH1A1
SCHEMBL4399721 0.69 HSD11B1 (0.32) HSD11B1
SCHEMBL4399725 0.69 HSD11B1 (0.32) HSD11B1
SCHEMBL13779854 0.69 EPHX2 (0.38) HSD11B1MEN1KMT2A
SCHEMBL14877443 0.69 HSD11B1 (0.31) HSD11B1MEN1KMT2AALDH1A1
SCHEMBL717502 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8475999-B2 Compound and photoresist composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-07-02 US disclosed
US-20110039209-A1 COMPOUND AND PHOTORESIST COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-02-17 US disclosed
US-7625689-B2 better line edge roughness in excimer laser lithography; supramolecule ester useful in photoresists e.g. pentaerythritol, tetrakis(3-(methoxymethyloxycarbonyl)cyclohexanecarboxylate) aka PECHOM and other adamantanyl and norbornyl derivatives SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-12-01 US disclosed
US-7576223-B2 Polymer of a (meth)acryloyloxy)ethoxycarbonyl)sulfonium sulfonate, e.g., 1-[2-(2-methylacryloyloxy)ethoxycarbonyl]tetrahydrothiophenium perfluorobutanesulfonate; used a an acid generator in excimer laser lithography; stable fine patterns without collapse and improved line edge roughness. SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-08-18 US disclosed
US-20080269506-A1 Chemical amplification type resist composition YAMADA AIRI 2008-10-30 US disclosed
US-7396899-B2 Chemical amplification type resist composition SUMITOMO CHEMICAL CO., LTD. (JP) 2008-07-08 US disclosed
US-20070123674-A1 Chemical amplification type resist composition YAMADA AIRI 2007-05-31 US disclosed
US-20070088131-A1 Sulfonate and resist composition TOISHI KOUJI 2007-04-19 US disclosed
US-7160669-B2 Chemical amplification type resist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-01-09 US disclosed
US-7135268-B2 Using aromatic sulfonate compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-11-14 US disclosed
US-20060160017-A1 Chemically amplified positive resist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-07-20 US disclosed
US-7001706-B2 Sulfonate and a resist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-02-21 US disclosed
US-6951706-B2 Sulfonate and resist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-10-04 US disclosed
US-20050014095-A1 Sulfonate and a resist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-01-20 US disclosed
US-20040152009-A1 Sulfonate and resist composition SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-05 US disclosed
US-20040138353-A1 Chemical amplification type resist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-07-15 US disclosed
US-20040029037-A1 Amplification type positive resist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269506-A1 Chemical amplification type resist composition ASIC1, POLR2B, POLR2A HSD11B1 3902/4885MEN1 3196/4885KMT2A 913/4885
US-20110039209-A1 COMPOUND AND PHOTORESIST COMPOSITION CONTAINING THE SAME RCOR3, RCN1, HRH4 HSD11B1 1229/4885MEN1 2367/4885KMT2A 2143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.